Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study

Ogura Yuichiro; Terasaki Hiroko; Gomi Fumi; Yuzawa Mitsuko; Iida Tomohiro; Honda Miki; Nishijo Koichi; Sowade Olaf; Komori Tetsushi; Schmidt-Erfurth Ursula; Simader Christian; Chong Victor

首页> 外文期刊>British journal of ophthalmology >Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study

【24h】

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study

机译：玻璃体腔注射阿柏西普注射液在湿性年龄相关性黄斑变性中的疗效和安全性：VIEW 2研究的日本亚组的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background/aims To evaluate efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with wet age-related macular degeneration (wAMD) from the VIEW 2 trial.

机译：背景/目的从VIEW 2试验中评估玻璃体腔注射阿柏西普（IVT-AFL）在日本湿性年龄相关性黄斑变性（wAMD）患者中的疗效和安全性。

著录项

来源
《British journal of ophthalmology》 |2015年第1期|共6页
作者
Ogura Yuichiro; Terasaki Hiroko; Gomi Fumi; Yuzawa Mitsuko; Iida Tomohiro; Honda Miki; Nishijo Koichi; Sowade Olaf; Komori Tetsushi; Schmidt-Erfurth Ursula; Simader Christian; Chong Victor;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study [J] . Ogura Yuichiro, Terasaki Hiroko, Gomi Fumi, British journal of ophthalmology . 2015,第1期

机译：玻璃体腔注射阿柏西普注射液在湿性年龄相关性黄斑变性中的疗效和安全性：VIEW 2研究的日本亚组的结果
2. A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] [J] . Clinical ophthalmology . 2017,第8期

机译：由研究者发起的单臂研究，用于玻璃体腔注射阿柏西普注射液对先前接受过兰尼单抗或贝伐单抗治疗的渗出性年龄相关性黄斑变性患者的疗效，安全性和耐受性（ASSESS研究）：12个月分析[更正]
3. A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-mo [J] . Rishi P Singh, Sunil K Srivastava, Justis P Ehlers, Clinical ophthalmology . 2015,第7期

机译：由研究者发起的单臂研究，用于玻璃体腔注射阿柏西普注射液对先前接受过兰尼单抗或贝伐单抗治疗的渗出性年龄相关性黄斑变性患者的疗效，安全性和耐受性（ASSESS研究）：12个月
4. Knowledge discovery in ophthalmology: analysis of wet form of Age-related Macular Degeneration treatment outcomes [C] . Magdalena Ulinska, Emanuel Tataj, Jan Mulawka, Conference on photonics applications in astronomy, communications, industry, and high-energy physics experiments . 2009

机译：眼科知识发现：与年龄相关的黄斑变性的湿润形式治疗结果分析
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study [O] . Yuichiro Ogura, Hiroko Terasaki, Fumi Gomi, -1

机译：玻璃体腔注射阿柏西普注射液治疗湿性年龄相关性黄斑变性的疗效和安全性：VIEW 2研究的日本亚组的结果
7. Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: Outcomes in the Japanese subgroup of the VIEW 2 study [O] . Ogura, Y, Terasaki, H, Gomi, F, 2014

机译：玻璃体腔注射阿柏西普注射液治疗湿性年龄相关性黄斑变性的有效性和安全性：VIEW 2研究的日本亚组的结果

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅